Results 181 to 190 of about 121,912 (288)

Estrogen Receptor Alpha-Expressing Neurons in Bed Nucleus of the Stria Terminalis and Hypothalamus Encoding Aggression and Mating. [PDF]

eNeuro
Wang WQ, Zhao HX, Shen XL, Zeng LZ, Geng HY.   +4 more
europepmc   +1 more source

Subcellular and Subnuclear Distributions of Estrogen Receptor .ALPHA. in Living Cells Using Green Fluorescent Protein and Immunohistochemistry.

, 2001
Maki Yoshida, Mayumi Nishi, Zenro Kizaki, Tadashi Sawada, Mitsuhiro Kawata   +4 more
openalex   +2 more sources

Comparing the effects of tibolone and hormone replacement therapy on endometrial estrogen receptor (ER) isoforms, ER-alpha and ER-beta: placebo controlled randomized study. [PDF]

, 2001
Ömür Taşkın, Gökhan Akkoyunlu, Ramazan Demir, S. Sadik, A Önoglu, J.M Wheeler   +5 more
openalex   +1 more source

Adjuvant pharmacological strategies for the musculoskeletal system during long‐term space missions

British Journal of Clinical Pharmacology, EarlyView., 2023
Abstract Despite 2 h of daily exercise training, muscle wasting and bone loss are still present after 6‐month missions to the international space station. Some crew members lose bone much faster than others. In preparation for missions to the Moon and Mars, space agencies are therefore reviewing their countermeasure portfolios.
Friederike Thomasius, Dominik Pesta, Jörn Rittweger   +2 more
wiley   +1 more source

Small phenolic compounds as potential endocrine disruptors interacting with estrogen receptor alpha. [PDF]

Front Endocrinol (Lausanne)
Alva-Gallegos R, Jirkovský E, Mladěnka P, Carazo A.   +3 more
europepmc   +1 more source

Estrogen receptor alpha gene polymorphisms Pvu II and Xba I influence association between leptin receptor gene polymorphism (Gln223Arg) and bone mineral density in young men [PDF]

, 2002
JM Koh, Kim Dj, JS Hong, J.Y. Park, KU Lee, Su‐Young Kim, GS Kim   +6 more
openalex   +1 more source

Physiologically Based Pharmacokinetic (PBPK) Model to Predict the Magnitude of Drug–Drug Interaction Between Fezolinetant and CYP1A2 Inhibitors

The Journal of Clinical Pharmacology, EarlyView.
Abstract Fezolinetant is a non‐hormonal, selective neurokinin 3 receptor antagonist approved in multiple countries including the United States, in Europe, and in Asia for the treatment of moderate to severe vasomotor symptoms in menopausal women. Fezolinetant is primarily metabolized by CYP1A2 and was found to be a sensitive substrate for CYP1A2 ...
Mary P. Choules, Yukio Otsuka, Jace C. Nielsen, Megumi Iwai, Peter L. Bonate   +4 more
wiley   +1 more source

17β-estradiol and estrogen receptor alpha protect mouse ovarian follicle development by repressing atresia. [PDF]

iScience
Ueno E, Watanabe M, Kondo Y, Nakagata N, Takeo T, Nakao S, Ogiwara K.   +6 more
europepmc   +1 more source

Trends in resource utilization for new‐onset psychosis hospitalizations at children's hospitals

Journal of Hospital Medicine, EarlyView.
Abstract Background Children with new‐onset psychosis often require hospitalization for medical evaluation. Objectives The goal of this study was to assess variations in the management of children with new‐onset psychosis and characterize trends in resource utilization.
Ankita Gupta, Matt Hall, Benjamin Masserano, Averi Wilson, Katherine Johnson, Clifford Chen, Lasya Challa, Harita Katragadda, Vineeta Mittal   +8 more
wiley   +1 more source

Distributions of estrogen receptors alpha and beta in sympathetic neurons of female rats: Enriched expression by uterine innervation [PDF]

, 2002
Elena V. Zoubina, Peter G. Smith
openalex   +1 more source